INR 7.07
(0.14%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | -1.16 Million | -16.12 Million | 20.06 Million | -8.12 Million | 2.7 Million |
Net Income | -2.64 Million | -71.53 Million | -597.59 Million | -4.71 Million | -5.51 Million |
Depreciation & Amortization | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 1.47 Million | -11.9 Million | 365.1 Million | -3.77 Million | 13.96 Million |
Other non-cash items | 11 Thousand | 67.31 Million | 133.19 Million | -4.18 Million | -5.75 Million |
Investing Cash Flow | - | - | -11.85 Million | 139 Thousand | -72 Thousand |
Investments in PPE | - | - | -15 Million | - | -72 Thousand |
Acquisitions | - | - | - | 139 Thousand | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | 3.15 Million | - | - |
Other Investing Activities | - | - | 3.15 Million | 139 Thousand | - |
Financing Cash Flow | 1.07 Million | 16.05 Million | -10.86 Million | 5.22 Million | - |
Debt repayment | -1.07 Million | -16.05 Million | -10.86 Million | -5.22 Million | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | 1.07 Million | 16.05 Million | -10.86 Million | 5.22 Million | - |
Accounts receivables | - | - | - | - | 146 Thousand |
Accounts payables | - | - | 33.57 Million | 4.34 Million | - |
Inventory | - | - | 85.78 Million | 204 Thousand | 11.67 Million |
Other working capital | 1.47 Million | -11.9 Million | 245.74 Million | -8.31 Million | 2.15 Million |
Cash at beginning of period | 1.2 Million | 1.27 Million | 3.92 Million | 6.68 Million | 4.05 Million |
Cash at end of period | 1.11 Million | 1.2 Million | 1.27 Million | 3.92 Million | 6.68 Million |
Capital Expenditure | - | - | -15 Million | - | -72 Thousand |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -90 Thousand | -68 Thousand | -2.64 Million | -2.76 Million | 2.62 Million |
Free Cash Flow | -1.16 Million | -16.12 Million | 5.06 Million | -8.12 Million | 2.62 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -5.00 | -303.00 | -2.64 Million | -1480.00 | -102.00 | -759.00 |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 1.47 Million | - | - | - |
Other non-cash items | 5.00 | 303.00 | 11 Thousand | 1480.00 | 102.00 | 759.00 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | 1.07 Million | - | - | - |
Debt repayment | - | - | -1.07 Million | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 1.07 Million | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | 1.47 Million | - | - | - |
Cash at beginning of period | - | - | 1.2 Million | - | - | - |
Cash at end of period | - | - | 1.11 Million | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -90 Thousand | - | - | - |
Free Cash Flow | - | - | -1.16 Million | - | - | - |
CRAVATEX
JGCHEM
COLFF
GRPTY
ALL-PI
002560